PK, G., IB, G., MC, S., P, V., SM, S., B, S. L., . . . E, Y. (2026). Effects of Lotilaner Ophthalmic Solution, 0.25% on Demodex Blepharitis Patients with Meibomian Gland Disease. Clinical ophthalmology (Auckland, N.Z.), 20, 527753. https://doi.org/10.2147/OPTH.S527753
Chicago Style (17th ed.) CitationPK, Gupta, Gaddie IB, Shultz MC, Vollmer P, Silverstein SM, Shen Lee B, O'Dell L, Dhamdhere K, and Yeu E. "Effects of Lotilaner Ophthalmic Solution, 0.25% on Demodex Blepharitis Patients with Meibomian Gland Disease." Clinical Ophthalmology (Auckland, N.Z.) 20 (2026): 527753. https://doi.org/10.2147/OPTH.S527753.
MLA (9th ed.) CitationPK, Gupta, et al. "Effects of Lotilaner Ophthalmic Solution, 0.25% on Demodex Blepharitis Patients with Meibomian Gland Disease." Clinical Ophthalmology (Auckland, N.Z.), vol. 20, 2026, p. 527753, https://doi.org/10.2147/OPTH.S527753.